HIMS Company Profile and Key Details

Q: Who are the executives of HIMS?

Ms. Melissa BairdChief Operations OfficerMr. Brian O'ShaughnessyChief Communications OfficerDr. Patrick Carroll M.D.Chief Medical Officer, Member of Medical Advisory Board & DirectorDr. Aimee Paik FAAD, M.D.Senior Vice President & Member of Medical Advisory BoardMr. Andrew DudumCo-Founder, Chairman & Chief Executive OfficerMr. Yemi OkupeChief Financial OfficerMs. Soleil Teubner BoughtonChief Legal Officer & Corporation Sec.Mr. Mike ChiChief Marketing OfficerMs. Amee ParekhSenior Vice President of HRMs. Irene A. BecklundSenior Vice President, Controller & Principal Accounting OfficerMr. Jonathan Spitzer C.F.A.Vice President of Investor Relations

NYSE : HIMS

Hims & Hers Health

$19.14

-0.7-3.53%

At Close 4:00 PM

62.14

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Hims & Hers Health, Inc. (HIMS) stock declined over -3.53%, trading at $19.14 on NYSE, down from the previous close of $19.84. The stock opened at $19.31, fluctuating between $18.76 and $19.50 in the recent session.

Stock Snapshot

19.84

Prev. Close

4.2B

Market Cap

18.755

Day Low

37.53

P/E Ratio

0.51

EPS (TTM)

0.23

Cash Flow per Share

19.31

Open

219.56M

Number of Shares

19.5

Day High

90.77%

Free Float in %

1.63

Book Value

21.85M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	19.31	19.50	18.76	19.14	23.36M
Apr 01, 2026	21.00	21.62	19.70	19.84	26.45M
Mar 31, 2026	18.78	21.00	18.64	20.77	34.32M
Mar 30, 2026	19.35	19.67	18.62	18.78	19.05M
Mar 27, 2026	20.58	20.60	19.18	19.38	22.21M
Mar 25, 2026	21.70	22.00	20.57	20.84	21.57M
Mar 24, 2026	22.21	22.30	21.09	21.34	26.24M
Mar 23, 2026	22.60	23.10	22.25	22.46	20.13M
Mar 20, 2026	23.95	24.25	21.70	22.02	32.96M
Mar 19, 2026	22.89	24.39	22.61	24.16	29.11M
Mar 18, 2026	24.70	25.04	23.15	23.15	34.85M
Mar 17, 2026	24.55	25.24	23.99	24.98	35.14M
Mar 16, 2026	24.22	25.17	23.52	24.88	37.73M
Mar 13, 2026	24.07	24.82	23.25	24.77	42.57M
Mar 12, 2026	26.84	27.24	23.76	23.84	67.52M
Mar 11, 2026	23.12	27.54	22.81	25.88	110.4M
Mar 10, 2026	24.00	26.03	22.43	23.47	117.95M
Mar 09, 2026	23.22	23.51	20.97	22.16	173.96M
Mar 06, 2026	15.54	15.84	15.21	15.74	14.33M
Mar 03, 2026	16.00	16.91	15.27	15.82	27.31M

Contact Details

San Francisco, CA 94123

United States

https://www.forhims.com 415 851 0195

About Company

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Stock Peers

NVST

-0.09-0.35%

Envista Holdings Corp$25.81 CON

-0.34-1.60%

Concentra Group Holdings Parent, Inc.$20.89 NEUE

NeueHealth, Inc.$6.75

Company Overview

Hims & Hers Health, Inc. (NYSE:HIMS) closed at $19.14 USD, losing -$0.70 (-3.53%) from the previous close of $19.84. The stock is currently mid-range between its 52-week high and low $13.74 and $70.43. With a market capitalization of about $4.20 billion, Hims & Hers Health, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~2.31). Key stats such as the average daily volume over the past year has been around 34.93 million shares, volume is running light vs its 52-week average. Headquartered in San Francisco, CA, Hims & Hers Health, Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Andrew Dudum, the company employs approximately 1,637 people and listed since September 13, 2019. Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -20.24%, SMA50 -43.45%, SMA200 -64.8%). The stock’s 14-day RSI is 18.83 (weak momentum), while the ATR of 1.79 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -77.85% below its high and over 13.54% above its low. Average 10-day trading volume of 25.08 million shares is below the 3-month average of 34.50 million, indicating normal recent market interest.

Valuation Metrics

Hims & Hers Health, Inc. trades at a P/E ratio of 33.86, slightly above the S&P 500 average, with a price-to-sales ratio of 1.79 and a price-to-book ratio of 8.03 trading at moderately above to book value. The P/FCF stands at 57.68, also below market averages.

Dividend & Fair Value

Hims & Hers Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.52. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 31.13% annually over the next five years. The latest quarter delivered EPS of $0.06. The next quarter is forecast at $0.03. Next year's EPS is expected at $69.91. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 4 Buy ratings, 15 Hold ratings, 2 Sell rating and 2 Strong Sell ratings. Price targets range from $85.00 to $16.50. The high target offers 344.1% upside. The low target suggests -13.79% downside. The mean target is $34.54. This offers 80.46% upside. Hims & Hers Health, Inc. earnings surprise history is a mixed track record. The quarter that ended November 03, 2025, missed forecasts by -29.52%. The prior quarter beat by -5.56%. Over the last six quarters, Apple has recorded several small beats. These include 13.26% in August 05, 2024.

Shareholding & Insider Activity

Hims & Hers Health, Inc. has 217.64 million shares outstanding. The public float is 197.56 million shares, elevated short interest at 35.46% of float. This equals 64.59 million shares. The short ratio is 2.03 days. Institutional investors hold 99.53% of the float. Insiders own 10.63%. Maltz Jules A. holds 7.71 million shares, Bard Alex has 7.35 million shares and Baird Melissa has 805.08 thousand shares. Over the past six months, insider transactions show net selling. They sold 255.94 thousand shares across 21 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Hims & Hers Health generated $872.00M in revenue, or $4.17 per share. Gross margin was 80.90%, operating margin -3.84%, and net profit margin -2.70%. Returns are negative, with ROA at -5.34% and ROE at -6.84%.
On valuation metrics, Hims & Hers Health trades at a P/E of 33.86, P/S of 1.79 and P/B of 8.03. The current ratio is 1.90 and quick ratio is 1.61. Operationally, the company’s inventory turnover is 5.31 and cash conversion cycle is -11.37 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 2.34, supported by a cash flow-to-debt ratio of 0.24.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Hims & Hers Health posted revenue of $872.00M, down slightly from $526.92M in the prior quarter. Gross profit was $705.43M (margin 80.90%). Operating income was - $33.46M (margin -3.8%). Net income was- $23.55M (EPS - $0.11).
The company ended the quarter with $220.98M in cash and short-term investments, a total debt of $9.95M, and net debt of - $86.72M. Total assets were $441.19M, with equity of $344.03M. Financials further reflected stability, with operating cash flow of $75.42M, free cash flow of $48.92M, and capital expenditures of - $26.49M.

Price Forecast & Outlook

Our AI price prediction model suggests that Hims & Hers Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 13.38%, with price expected at $21.70 by April 16, 2026, within a range of $18.44 to $24.87 3-Month Outlook: Projected rise of 94.15%, reaching $37.16 by July 01, 2026, with a range of $33.27 to $39.88. 1-Year Outlook: Projected gain of 69.96%, with price at $32.53 by April 02, 2027, within a range of $28.54 to $36.50.

Key Takeaways

Hims & Hers Health, Inc. (NYSE:HIMS) shares are flat -6.16% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Hims & Hers Health, Inc. trading at a premium to the broader market with a P/E of 33.86. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $25.48, suggesting 33.12% upside. Our AI forecast model points to short-term strength (13.38% over two weeks), a medium-term rise (94.15% over three months), and a longer-term gain (69.96% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Hims & Hers Health, Inc. (HIMS) stock price?

Hims & Hers Health, Inc. (NYSE: HIMS) stock price is $19.14 in the last trading session. During the trading session, HIMS stock reached the peak price of $19.50 while $18.76 was the lowest point it dropped to. The percentage change in HIMS stock occurred in the recent session was -3.53% while the dollar amount for the price change in HIMS stock was - $0.70.

HIMS's industry and sector of operation?

The NYSE listed HIMS is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector. Hims & Hers Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HIMS?

Ms. Melissa Baird
Chief Operations Officer
Mr. Brian O'Shaughnessy
Chief Communications Officer
Dr. Patrick Carroll M.D.
Chief Medical Officer, Member of Medical Advisory Board & Director
Dr. Aimee Paik FAAD, M.D.
Senior Vice President & Member of Medical Advisory Board
Mr. Andrew Dudum
Co-Founder, Chairman & Chief Executive Officer
Mr. Yemi Okupe
Chief Financial Officer
Ms. Soleil Teubner Boughton
Chief Legal Officer & Corporation Sec.
Mr. Mike Chi
Chief Marketing Officer
Ms. Amee Parekh
Senior Vice President of HR
Ms. Irene A. Becklund
Senior Vice President, Controller & Principal Accounting Officer
Mr. Jonathan Spitzer C.F.A.
Vice President of Investor Relations

How HIMS did perform over past 52-week?

HIMS's closing price is 39.3% higher than its 52-week low of $13.74 where as its distance from 52-week high of $70.43 is -72.82%.

How many employees does HIMS have?

Number of HIMS employees currently stands at 1,637.

Link for HIMS official website?

Official Website of HIMS is: https://www.forhims.com

How do I contact HIMS?

HIMS could be contacted at phone 415 851 0195 and can also be accessed through its website. HIMS operates from 2269 Chestnut Street, San Francisco, CA 94123, United States.

How many shares of HIMS are traded daily?

HIMS stock volume for the day was 21.85M shares. The average number of HIMS shares traded daily for last 3 months was 34.93M.

What is the market cap of HIMS currently?

The market value of HIMS currently stands at $4.20B with its latest stock price at $19.14 and 219.56M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1637
Beta	2.31
Sales or Revenue	$872.00M
5Y Sales Change%	0.269%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Equipment & Services

HIMS Company Profile and Key Details

Hims & Hers Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook